|
Volumn 424, Issue 6950, 2003, Pages 738-739
|
Aspirin, ubiquitin and cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG PRODUCTS;
PROTEINS;
RESEARCH;
TUMOR SYNDROME;
TUMORS;
ACETYLSALICYLIC ACID;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
TUMOR SUPPRESSOR PROTEIN;
TUMOR SUPPRESSOR PROTEIN CYLD;
UBIQUITIN;
UNCLASSIFIED DRUG;
CHUK PROTEIN, HUMAN;
CYLD PROTEIN, HUMAN;
I KAPPA B KINASE;
IKBKB PROTEIN, HUMAN;
IKBKE PROTEIN, HUMAN;
PROTEIN;
PROTEIN SERINE THREONINE KINASE;
TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;
MEDICINE;
CARCINOGENESIS;
CYLINDROMA;
HUMAN;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
SHORT SURVEY;
DRUG ANTAGONISM;
GENETICS;
METABOLISM;
NEOPLASM;
NOTE;
SIGNAL TRANSDUCTION;
SYNDROME;
ASPIRIN;
HUMANS;
I-KAPPA B KINASE;
NEOPLASMS;
NF-KAPPA B;
PROTEIN-SERINE-THREONINE KINASES;
PROTEINS;
SIGNAL TRANSDUCTION;
SYNDROME;
TNF RECEPTOR-ASSOCIATED FACTOR 2;
TUMOR SUPPRESSOR PROTEINS;
UBIQUITIN;
|
EID: 0041967217
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/424738a Document Type: Short Survey |
Times cited : (37)
|
References (15)
|